CONMED
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $345,944 | $316,701 | $330,748 | $311,632 |
Gross Profit | 198,344 | 178,995 | 173,154 | 161,978 |
EBITDA | 70,505 | 83,681 | 47,107 | 54,933 |
EBIT | 52,499 | 65,707 | 34,342 | 42,287 |
Net Income | 33,755 | 48,984 | 29,976 | 19,709 |
Net Change In Cash | 345,944 | 316,701 | 330,748 | 311,632 |
Free Cash Flow | 39,298 | 47,784 | 39,716 | 27,086 |
Cash | 24,459 | 38,467 | 28,869 | 33,855 |
Basic Shares | 31,112 | 31,112 | 31,106 | 31,272 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,307,015 | $1,244,744 | $1,045,472 | $1,010,635 |
Gross Profit | 733,032 | 676,245 | 571,245 | 568,036 |
EBITDA | 272,183 | 192,477 | 7,798 | 158,384 |
EBIT | 200,326 | 141,077 | -41,957 | 108,590 |
Net Income | 132,423 | 64,459 | -80,582 | 62,542 |
Net Change In Cash | 1,307,015 | 1,244,744 | 1,045,472 | 1,010,635 |
Cost of Revenue | 8,836 | -6,509 | ||
Free Cash Flow | 153,884 | 106,316 | 11,580 | 96,904 |
Cash | 24,459 | 24,296 | 28,942 | 20,847 |
Basic Shares | 31,112 | 31,548 | 30,040 | 32,216 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $1.34 |
2024-09-30 | $1.05 |
2024-06-30 | $0.98 |
2024-03-31 | $0.79 |
